← Back to Search

Device

Parasym Device (of Parasym Ltd, UK) using Transcutaneous Vagus Nerve Stimulation (t-VNS) for Cognitive Impairment

N/A
Waitlist Available
Led By Amy Zheng, PhD
Research Sponsored by Casa Colina Hospital and Centers for Healthcare
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at baseline, at week 3, and at week 7
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing a device that sends gentle electrical signals to a nerve in the neck to help women with Long COVID who have trouble thinking clearly. The goal is to improve brain function and reduce symptoms like 'brain fog.'

Eligible Conditions
  • Cognitive Impairment
  • Post-COVID Syndrome

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at baseline, at week 3, and at week 7
This trial's timeline: 3 weeks for screening, Varies for treatment, and at baseline, at week 3, and at week 7 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in Dimensional Change Card Sort Test (DCCS) scores
Change in Flanker Inhibitory Control and Attention Test (Flanker) scores
Change in List Sorting Working Memory scores
+2 more
Secondary study objectives
Change in BURNS Anxiety Inventory scores
Mental Depression
Change in Fatigue Severity Scale scores
+5 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Transcutaneous Vagus Nerve Stimulation (t-VNS)Experimental Treatment1 Intervention
Participants will receive 60 minutes of t-VNS stimulation every day for 10 consecutive days while wearing a fitness tracker.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Parasym Device (of Parasym Ltd, UK) using Transcutaneous Vagus Nerve Stimulation (t-VNS)
2022
N/A
~30

Find a Location

Who is running the clinical trial?

Casa Colina Hospital and Centers for HealthcareLead Sponsor
10 Previous Clinical Trials
320 Total Patients Enrolled
Amy Zheng, PhDPrincipal InvestigatorCasa Colina Hospital and Centers for Healthcare
1 Previous Clinical Trials
24 Total Patients Enrolled
~7 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top